1
|
Kramarova EP, Lyakhmun DN, Tarasenko DV, Borisevich SS, Khamitov EM, Yusupova AR, Korlyukov AA, Romanenko AR, Shmigol TA, Bylikin SY, Baukov YI, Negrebetsky VV. Reaction of Picolinamides with Ketones Producing a New Type of Heterocyclic Salts with an Imidazolidin-4-One Ring. Molecules 2023; 29:206. [PMID: 38202789 PMCID: PMC10780162 DOI: 10.3390/molecules29010206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 12/20/2023] [Accepted: 12/22/2023] [Indexed: 01/12/2024] Open
Abstract
Reactions of picolinamides with 1,3-propanesultone in methanol followed by the treatment with ketones led to a series of previously unknown chemical transformations, yielding first pyridinium salts (2a-f), with a protonated endocyclic nitrogen atom, and then heterocyclic salts (3a-j) containing an imidazolidin-4-one ring. The structures of intermediate and final products were determined by IR and 1H, 13C NMR spectroscopy, and X-ray study. The effects of the ketone and alcohol structures on the product yield were studied by quantum-chemical calculations. The stability of salts 3a-j towards hydrolysis and alcoholysis makes them excellent candidates for the search for new types of biologically active compounds.
Collapse
Affiliation(s)
- Eugenia P. Kramarova
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | - Dmitry N. Lyakhmun
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | - Dmitry V. Tarasenko
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | - Sophia S. Borisevich
- Ufa Institute of Chemistry, Oktyabrya Aven., 71, 450054 Ufa, Russia; (S.S.B.); (E.M.K.); (A.R.Y.)
| | - Edward M. Khamitov
- Ufa Institute of Chemistry, Oktyabrya Aven., 71, 450054 Ufa, Russia; (S.S.B.); (E.M.K.); (A.R.Y.)
| | - Alfia R. Yusupova
- Ufa Institute of Chemistry, Oktyabrya Aven., 71, 450054 Ufa, Russia; (S.S.B.); (E.M.K.); (A.R.Y.)
| | - Alexander A. Korlyukov
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
- A.N.Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova St. 28, Bl. 1, 119334 Moscow, Russia;
| | - Alexander R. Romanenko
- A.N.Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova St. 28, Bl. 1, 119334 Moscow, Russia;
- D.I. Mendeleev Russian University of Chemical Technology, Miusskaya Sq., 9, 125047 Moscow, Russia
| | - Tatiana A. Shmigol
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | | | - Yuri I. Baukov
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | - Vadim V. Negrebetsky
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| |
Collapse
|
2
|
Xie L, Zhao C, Wang Z, Chen Z, Zhao Y, Liu X, Xu X, Liu W, Li X, Wu L. Synthesis of Polycyclic Imidazolidinones via Cascade [3 + 2]-Annulation of β-Oxo-acrylamides with Cyclic N-Sulfonyl Imines. J Org Chem 2023; 88:15805-15816. [PMID: 37906181 DOI: 10.1021/acs.joc.3c01878] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2023]
Abstract
An Et3N-catalyzed cascade [3 + 2]-annulation of β-oxo-acrylamides with cyclic N-sulfonyl ketimines or sulfamate-derived imines is developed under mild reaction conditions, which provides a concise and efficient route to access valuable sultam- or sulfamidate-fused imidazolidinone derivatives in good to excellent yields (80-95% yields) with excellent diastereoselectivities (>20:1 drs). The current protocol features atom economy, a transition-metal-free process, and broad functional group tolerance. Moreover, the asymmetric variant of the [3 + 2]-cycloaddition reaction was achieved in the presence of diphenylethanediamine or quinine-based bifunctional squaramide organocatalysts C-1 and C-11, giving the corresponding chiral polycyclic imidazolidinones in 68-90% yields with 25-94% ees and >20:1 drs in all cases.
Collapse
Affiliation(s)
- Lei Xie
- School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, Shandong, P. R. China
- Liaocheng Key Laboratory of Quality Control and Pharmacodynamic Evaluation of Ganoderma Lucidum, Liaocheng 252000, Shandong, P. R. China
| | - Chenyi Zhao
- School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, Shandong, P. R. China
- Liaocheng Key Laboratory of Quality Control and Pharmacodynamic Evaluation of Ganoderma Lucidum, Liaocheng 252000, Shandong, P. R. China
| | - Zhaoxue Wang
- School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, Shandong, P. R. China
- Liaocheng Key Laboratory of Quality Control and Pharmacodynamic Evaluation of Ganoderma Lucidum, Liaocheng 252000, Shandong, P. R. China
| | - Zirui Chen
- School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, Shandong, P. R. China
- Liaocheng Key Laboratory of Quality Control and Pharmacodynamic Evaluation of Ganoderma Lucidum, Liaocheng 252000, Shandong, P. R. China
| | - Yingying Zhao
- School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, Shandong, P. R. China
- Liaocheng Key Laboratory of Quality Control and Pharmacodynamic Evaluation of Ganoderma Lucidum, Liaocheng 252000, Shandong, P. R. China
| | - Xinghan Liu
- School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, Shandong, P. R. China
- Liaocheng Key Laboratory of Quality Control and Pharmacodynamic Evaluation of Ganoderma Lucidum, Liaocheng 252000, Shandong, P. R. China
| | - Xiangdong Xu
- Liaocheng Inspection and Testing Center, Liaocheng 252000, Shandong, P. R. China
| | - Wanxing Liu
- The Non-Public Enterprise Service Center of Liaocheng, Liaocheng 252000, Shandong, P. R. China
| | - Xiaojing Li
- School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, Shandong, P. R. China
- Liaocheng Key Laboratory of Quality Control and Pharmacodynamic Evaluation of Ganoderma Lucidum, Liaocheng 252000, Shandong, P. R. China
| | - Lingang Wu
- School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, Shandong, P. R. China
- Liaocheng Key Laboratory of Quality Control and Pharmacodynamic Evaluation of Ganoderma Lucidum, Liaocheng 252000, Shandong, P. R. China
| |
Collapse
|
3
|
Kumar S, Patil MT, Salunke DB. Indole based prostate cancer agents. PHYSICAL SCIENCES REVIEWS 2022. [DOI: 10.1515/psr-2021-0131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
Cancer weakens the immune system which fails to fight against the rapidly growing cells. Among the various types of cancers, prostate cancer (PCa) is causing greater number of deaths in men after lung cancer, demanding advancement to prevent, detect and treat PCa. Several small molecule heterocycles and few peptides are being used as oncological drugs targeting PCa. Heterocycles are playing crucial role in the development of novel cancer chemotherapeutics as well as immunotherapeutics. Indole skeleton, being a privileged structure has been extensively used for the discovery of novel anticancer agents and the application of indole derivatives against breast cancer is well documented. The present article highlights the usefulness of indole linked heterocyclic compounds as well as the fused indole derivatives against prostate cancer.
Collapse
Affiliation(s)
- Sunil Kumar
- Department of Chemistry and Centre for Advanced Studies in Chemistry , Panjab University , Chandigarh , 160014 , India
- Department of Chemistry , J. C. Bose University of Science and Technology, YMCA , Faridabad 121006 , Haryana , India
| | - Madhuri T. Patil
- Mehr Chand Mahajan DAV College for Women , Sector 36A , Chandigarh 160036 , India
| | - Deepak B. Salunke
- Department of Chemistry and Centre for Advanced Studies in Chemistry , Panjab University , Chandigarh , 160014 , India
- National Interdisciplinary Centre of Vaccine, Immunotherapeutics and Antimicrobials , Panjab University , Chandigarh 160014 , India
| |
Collapse
|
4
|
Song F, Bian Y, Liu J, Li Z, Zhao L, Fang J, Lai Y, Zhou M. Indole Alkaloids, Synthetic Dimers and Hybrids with Potential In Vivo Anticancer Activity. Curr Top Med Chem 2021; 21:377-403. [PMID: 32901583 DOI: 10.2174/1568026620666200908162311] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Revised: 08/02/2020] [Accepted: 08/12/2020] [Indexed: 11/22/2022]
Abstract
Indole, a heterocyclic organic compound, is one of the most promising heterocycles found in natural and synthetic sources since its derivatives possess fascinating structural diversity and various therapeutic properties. Indole alkaloids, synthetic dimers and hybrids could act on diverse targets in cancer cells, and consequently, possess potential antiproliferative effects on various cancers both in vitro and in vivo. Vinblastine, midostaurin, and anlotinib as the representative of indole alkaloids, synthetic dimers and hybrids respectively, have already been clinically applied to treat many types of cancers, demonstrating indole alkaloids, synthetic dimers and hybrids are useful scaffolds for the development of novel anticancer agents. Covering articles published between 2010 and 2020, this review emphasizes the recent development of indole alkaloids, synthetic dimers and hybrids with potential in vivo therapeutic application for cancers.
Collapse
Affiliation(s)
- Feng Song
- Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou 253023, Shandong, China
| | - Yunqiang Bian
- Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou 253023, Shandong, China
| | - Jing Liu
- Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou 253023, Shandong, China
| | - Zhenghua Li
- Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou 253023, Shandong, China
| | - Li Zhao
- Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou 253023, Shandong, China
| | - Junman Fang
- School of Life Sciences, Dezhou University, Dezhou 253023, Shandong, China
| | - Yonghong Lai
- School of Life Sciences, Dezhou University, Dezhou 253023, Shandong, China
| | - Meng Zhou
- School of Life Sciences, Dezhou University, Dezhou 253023, Shandong, China
| |
Collapse
|
5
|
Jia Y, Wen X, Gong Y, Wang X. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity. Eur J Med Chem 2020; 200:112359. [PMID: 32531682 DOI: 10.1016/j.ejmech.2020.112359] [Citation(s) in RCA: 55] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Revised: 04/09/2020] [Accepted: 04/16/2020] [Indexed: 02/07/2023]
Abstract
Cancer chemotherapy is frequently hampered by drug resistance, so the resistance to anticancer agents represents one of the major obstacles for the effective cancer treatment. Indole derivatives have the potential to act on diverse targets in cancer cells and exhibit promising activity against drug-resistant cancers. Moreover, some indole-containing compounds such as Semaxanib, Sunitinib, Vinorelbine, and Vinblastine have already been applied in clinics for various kinds of cancer even drug-resistant cancer therapy. Thus, indole derivatives are one of significant resources for the development of novel anti-drug-resistant cancer agents. This review focuses on the recent development of indole derivatives with potential therapeutic application for drug-resistant cancers, and the mechanisms of action, the critical aspects of design as well as structure-activity relationships, covering articles published from 2010 to 2020.
Collapse
Affiliation(s)
- Yanshu Jia
- Chongqing Institute of Engineering, Chongqing, 400056, China
| | - Xiaoyue Wen
- The Institute of Infection and Inflammation, China Three Gorges University, Yichang, Hubei, 443000, China
| | - Yufeng Gong
- The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, 157000, China
| | - Xuefeng Wang
- Department of Surgery, Zhuji Affiliated Hospital of Shaoxing University, Zhejiang Province, 311800, China.
| |
Collapse
|
6
|
Kanyiva KS, Tane M, Shibata T. Iodine-Catalyzed Synthesis of Chiral 4-Imidazolidinones Using α-Amino Acid Derivatives via Dehydrogenative N–H/C(sp3)–H Coupling. J Org Chem 2019; 84:12773-12783. [DOI: 10.1021/acs.joc.9b01154] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Kyalo Stephen Kanyiva
- Global Center of Science and Engineering, School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - Marina Tane
- Department of Chemistry and Biochemistry, School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - Takanori Shibata
- Department of Chemistry and Biochemistry, School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| |
Collapse
|
7
|
Attorresi CI, Bonifazi EL, Ramírez JA, Gola GF. One-step synthesis of N,N'-substituted 4-imidazolidinones by an isocyanide-based pseudo-five-multicomponent reaction. Org Biomol Chem 2019; 16:8944-8949. [PMID: 30452056 DOI: 10.1039/c8ob02229a] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
A pseudo-five-multicomponent reaction involving an isocyanide, a primary amine, two molecules of formaldehyde and water is reported, which gives N,N'-substituted 4-imidazolidinones when trifluoroethanol is used as the solvent. The reaction proceeds with good yields and with a wide variety of amines and isocyanides, providing an efficient new entry to these heterocycles. A preliminary study of the reaction mechanism suggests that trifluoroethanol, although acting as the solvent, is directly involved as a reagent in the reaction pathway.
Collapse
Affiliation(s)
- Cecilia I Attorresi
- Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Ciudad Autónoma de Buenos Aires, C1428EGA, Argentina
| | | | | | | |
Collapse
|
8
|
|
9
|
Bolchi C, Bavo F, Regazzoni L, Pallavicini M. Preparation of enantiopure methionine, arginine, tryptophan, and proline benzyl esters in green ethers by Fischer–Speier reaction. Amino Acids 2018; 50:1261-1268. [DOI: 10.1007/s00726-018-2599-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2018] [Accepted: 06/01/2018] [Indexed: 11/30/2022]
|
10
|
Zhu H, Wang Y, Song C, Feng Q, Wu J, Zhao S, Gui L, Zhang X, Zhao M, Peng S. Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent. Oncotarget 2018; 9:268-281. [PMID: 29416612 PMCID: PMC5787463 DOI: 10.18632/oncotarget.19374] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2017] [Accepted: 07/06/2017] [Indexed: 01/01/2023] Open
Abstract
The impact of soluble P-selectin on tumor growth, thrombosis and inflammation has been individually documented. Whether the down-regulation of P-selectin expression can simultaneously slow the tumor growth, inhibit the thrombosis and attenuate the inflammatory response remains unknown. In this context, (2'S,5'S)- tetrahydropyrazino[1',2':1,6]-di{2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole}-1',4'-dione (THPDTPI) was designed as an inhibitor of P-selectin. The suitable docking of THPDTPI towards the active site of P-selectin, the significant down-regulation of THPDTPI to P-selectin expression, and the direct action of THPDTPI on P-selectin suggest that P-selectin could be a target of THPDTPI. In vivo THPDTPI possesses the anti-tumor activity, the anti-thrombotic activity and the anti-inflammatory activity. This implies that targeting P-selectin is of essential importance for this triple activity. The minimal effective doses of THPDTPI inhibiting the tumor growth, the rat arterial thrombosis and the mouse ear edema are 0.01 μmol/kg, 0.1 μmol/kg and 0.001 μmol/kg, respectively. Atomic force microscopy images and FT-MS spectra showed that the adhesion of THPDTPI onto the surfaces of the platelets may be the first step of P-selectin targeting. Besides, the dependence of the triple action of THPDTPI inhibiting the tumor growth, the thrombosis and the inflammation on the decrease of the soluble P-selectin led to the correlation of the soluble P-selectin with the serum TNF-α and serum IL-8.
Collapse
Affiliation(s)
- Haimei Zhu
- College of Pharmaceutical Sciences of Capital Medical University, Beijing, China
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China
- Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, China
| | - Yuji Wang
- College of Pharmaceutical Sciences of Capital Medical University, Beijing, China
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China
- Beijing Laboratory of Biomedical Materials, Beijing, China
| | - Ce Song
- Guangxi Pusen Biotechnology Co. Ltd., Guilin, China
| | - Qiqi Feng
- College of Pharmaceutical Sciences of Capital Medical University, Beijing, China
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China
- Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, China
| | - Jianhui Wu
- College of Pharmaceutical Sciences of Capital Medical University, Beijing, China
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China
- Beijing Laboratory of Biomedical Materials, Beijing, China
| | - Shurui Zhao
- College of Pharmaceutical Sciences of Capital Medical University, Beijing, China
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China
- Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, China
| | - Lin Gui
- College of Pharmaceutical Sciences of Capital Medical University, Beijing, China
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China
- Beijing Laboratory of Biomedical Materials, Beijing, China
| | - Xiaoyi Zhang
- College of Pharmaceutical Sciences of Capital Medical University, Beijing, China
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China
- Beijing Laboratory of Biomedical Materials, Beijing, China
| | - Ming Zhao
- College of Pharmaceutical Sciences of Capital Medical University, Beijing, China
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China
- Beijing Laboratory of Biomedical Materials, Beijing, China
- Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - Shiqi Peng
- College of Pharmaceutical Sciences of Capital Medical University, Beijing, China
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China
- Beijing Laboratory of Biomedical Materials, Beijing, China
| |
Collapse
|
11
|
Bolchi C, Bavo F, Pallavicini M. One-step preparation of enantiopure l- or d-amino acid benzyl esters avoiding the use of banned solvents. Amino Acids 2017; 49:965-974. [DOI: 10.1007/s00726-017-2400-y] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2017] [Accepted: 02/22/2017] [Indexed: 11/29/2022]
|
12
|
Li S, Wang A, Gu F, Wang Z, Tian C, Qian Z, Tang L, Gu Y. Novel harmine derivatives for tumor targeted therapy. Oncotarget 2016; 6:8988-9001. [PMID: 25940702 PMCID: PMC4496197 DOI: 10.18632/oncotarget.3276] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2014] [Accepted: 04/10/2015] [Indexed: 12/14/2022] Open
Abstract
Harmine is a beta-carboline alkaloid found in medicinal plant PeganumHarmala, which has served as a folk anticancer medicine. However, clinical applications of harmine were limited by its low pharmacological effects and noticeable neurotoxicity. In this study, we modified harmine to increase the therapeutic efficacy and to decrease the systemic toxicity. Specifically, two tumor targeting harmine derivatives 2DG-Har-01 and MET-Har-02 were synthesized by modifying substituent in position-2, -7 and -9 of harmine ring with two different targeting group2-amino-2-deoxy-D-glucose (2DG) and Methionine (Met), respectively. Their therapeutic efficacy and toxicity were investigated both in vitro and in vivo. Results suggested that the two newharmine derivatives displayed much higher therapeutic effects than non-modified harmine. In particular, MET-Har-02 was more potent than 2DG-Har-01 with promising potential for targeted cancer therapy.
Collapse
Affiliation(s)
- Siwen Li
- Department of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Arlington, TX, USA
| | - Aqin Wang
- Department of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Arlington, TX, USA
| | - Fan Gu
- Department of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Arlington, TX, USA
| | - Zhaohui Wang
- Department of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Arlington, TX, USA
| | - Caiping Tian
- Department of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Arlington, TX, USA
| | - Zhiyu Qian
- Department of Biomedical Engineering, School of Automation, Nanjing University of Aeronautics and Astronautics, Nanjing, China
| | - Liping Tang
- Department of Bioengineering, University of Texas at Arlington, Arlington, TX, USA
| | - Yueqing Gu
- Department of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Arlington, TX, USA
| |
Collapse
|
13
|
Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MND. Fragment-based QSAR model toward the selection of versatile anti-sarcoma leads. Eur J Med Chem 2011; 46:5910-6. [DOI: 10.1016/j.ejmech.2011.09.055] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2011] [Revised: 09/24/2011] [Accepted: 09/29/2011] [Indexed: 12/17/2022]
|